Company Comparison
Syros Pharmaceuticals vs AI Therapeutics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Syros Pharmaceuticals | AI Therapeutics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | — | San Diego |
| Founded | — | — |
| Status | Active | Active |
| Last Funding Stage | — | Series A |
| Total Funding | — | $48M |
| Valuation | — | — |
What They Build
Syros Pharmaceuticals
Clinical-stage biotech developing cancer treatments by controlling gene expression using proprietary gene control platforms.
AI Therapeutics
A San Diego biotech company using AI to accelerate drug discovery and development processes.
Key Investors
Syros Pharmaceuticals
AI Therapeutics
No investors listed.
Sector Overlap
Both Syros Pharmaceuticals and AI Therapeutics operate in Biotech.
Browse all Biotech companies →